Drug Watch

StrataGraft Approved for Thermal Burns in Adults
June 17, 2021

Mallinckrodt announces the FDA approval of StrataGraft (allogeneic cultured keratinocytes and dermal fibroblasts in murine collagen – dsat) for the treatment of adults with thermal burns.

Molluscum Contagiosum Treatment Demonstrates Success in Phase 3 Trial
June 15, 2021

The B-SIMPLE4 phase 3 trial achieved positive efficacy results for the treatment of molluscum contagiosum.

Secukinumab Approved for Plaque Psoriasis in Children, Adolescents
June 11, 2021

John Browning, MD, FAAD, FAAP, MBA, discusses the impact of the recent FDA approval of secukinumab (Cosentyx, Novartis) for the treatment of moderate to severe plaque psoriasis in children and adolescents.